Richters A, Aben KKH, Kiemeney LALM. The global burden of urinary bladder cancer: an update. World J Urol. 2020;38:1895–904.

Article  PubMed  Google Scholar 

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7–33.

Article  PubMed  Google Scholar 

Aron M. Variant histology in bladder cancer—current understanding of pathologic subtypes. Curr Urol Rep. 2019;20:1–13.

Article  Google Scholar 

Magers MJ, Lopez-Beltran A, Montironi R, Williamson SR, Kaimakliotis HZ, Cheng L. Staging of bladder cancer. Histopathology. 2019;74:112–34.

Article  PubMed  Google Scholar 

Lenis AT, Lec PM, Chamie K. Bladder cancer a review. JAMA. 2020;324:1980–91.

Article  CAS  PubMed  Google Scholar 

Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, et al. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guidelines. J Urol. 2017;198:552–9.

Article  PubMed  PubMed Central  Google Scholar 

Flaig TW, Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, et al. Bladder cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2020;18:329–54.

Article  Google Scholar 

Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, et al. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO Guideline. J Urol. 2017;198:552–9.

Article  PubMed  PubMed Central  Google Scholar 

Witjes JA, Bruins HM, Cathomas R, Compérat EM, Cowan NC, Gakis G, et al. European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol. 2021;79:82–104.

Article  CAS  PubMed  Google Scholar 

Rodler S, Solyanik O, Ingenerf M, Fabritius M, Schulz GB, Jokisch F, et al. Accuracy and prognostic value of radiological lymph node features in variant histologies of bladder cancer. World J Urol. 2022;40:1707–14.

Article  PubMed  PubMed Central  Google Scholar 

Caglic I, Panebianco V, Vargas HA, Bura V, Woo S, Pecoraro M, et al. MRI of Bladder cancer: local and nodal staging. J Magn Reson Imaging. 2020;52:649–67.

Article  PubMed  Google Scholar 

Momota M, Hatakeyama S, Tokui N, Sato T, Yamamoto H, Tobisawa Y, et al. The impact of preoperative severe renal insufficiency on poor postsurgical oncological prognosis in patients with urothelial carcinoma. Eur Urol Focus. 2019;5:1066–73.

Article  PubMed  Google Scholar 

Apolo AB, Riches J, Schöder H, Akin O, Trout A, Milowsky MI, et al. Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancer. J Clin Oncol. 2010;28:3973–8.

Article  PubMed  PubMed Central  Google Scholar 

Sharma A, Mete UK, Sood A, Kakkar N, Gorla AKR, Mittal BR. Utility of early dynamic and delayed post-diuretic 18 F-FDG PET/CT SUV max in predicting tumour grade and T-stage of urinary bladder carcinoma: results from a prospective single centre study. Br J Radiol. 2017;90:20160787.

Article  PubMed  PubMed Central  Google Scholar 

Uttam M, Pravin N, Anish B, Nandita K, Arup M. Is [F-18]-fluorodeoxyglucose FDG-PET/CT better than ct alone for the preoperative lymph node staging of muscle invasive bladder cancer? Int Braz J Urol. 2016;42(2):234–41.

Article  PubMed  PubMed Central  Google Scholar 

Guney IB, Kucuker KA, Izol V, Kibar M. The role and effect of FDG-PET/CT on patient management and restaging of bladder carcinoma. Turk J Urol. 2019;45(6):423–30.

Article  PubMed  PubMed Central  Google Scholar 

Rajesh A, Sokhi HK, Fung R, Mulcahy KA, Bankart MJ. Bladder cancer: evaluation of staging accuracy using dynamic MRI. Clin Radiol. 2011;66(12):1140–5.

Article  CAS  PubMed  Google Scholar 

Tekes A, Kamel I, Imam K, Szarf G, Schoenberg M, Nasir K, et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR Am J Roentgenol. 2005;184(1):121–7.

Article  PubMed  Google Scholar 

Lawrentschuk N, Lee ST, Scott AM. Current role of PET, CT, MR for invasive bladder cancer. Curr Urol Rep. 2013;14(2):84–9.

Article  PubMed  Google Scholar 

Baltaci S, Resorlu B, Yagci C, Turkolmez K, Gogus C, Beduk Y. Computerized tomography for detecting perivesical infiltration and lymph node metastasis in invasive bladder carcinoma. Urol Int. 2008;81(4):399–402.

Article  PubMed  Google Scholar 

Tritschler S, Mosler C, Straub J, Buchner A, Karl A, Graser A, et al. Staging of muscle-invasive bladder cancer: can computerized tomography help us to decide on local treatment? World J Urol. 2012;30(6):827–31.

Article  PubMed  Google Scholar 

Herr HW. Routine CT scan in cystectomy patients: does it change management? Urology. 1996;47(3):324–5.

Article  CAS  PubMed  Google Scholar 

Nayak B, Dogra PN, Naswa N, Kumar R. Diuretic 18F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique. Eur J Nucl Med Mol Imaging. 2013;40(3):386–93.

Article  CAS  PubMed  Google Scholar 

Harkirat S, Anand S, Jacob M. Forced diuresis and dual-phase F-fluorodeoxyglucose-PET/CT scan for restaging of urinary bladder cancers. Indian J Radiol Imaging. 2010;20(1):13–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anjos DA, Etchebehere EC, Ramos CD, Santos AO, Albertotti C, Camargo EE. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer. J Nucl Med. 2007;48(5):764–70.

Article  PubMed  Google Scholar 

Galgano SJ, Rais-Bahrami S, Porter KK, Burgan C. The role of imaging in bladder cancer diagnosis and staging. Diagnostics. 2020;10:1–16.

Article  Google Scholar 

Ha HK, Koo PJ, Kim SJ. Diagnostic accuracy of 18 F FDG PET/CT for preoperative lymph node staging in newly diagnosed bladder cancer patients: a systematic review and meta-analysis. Oncology. 2018;95:31–8.

Article  CAS  PubMed  Google Scholar 

Soubra A, Hayward D, Dahm P, Goldfarb R, Froehlich J, Jha G, et al. The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis. World J Urol. 2016;34:1229–37.

Article  PubMed  Google Scholar 

Crozier J, Papa N, Perera M, Ngo B, Bolton D, Sengupta S, et al. Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis. World J Urol. 2019;37:667–90.

Article  PubMed  Google Scholar 

Vind-Kezunovic S, Bouchelouche K, Ipsen P, Høyer S, Bell C, Bjerggaard Jensen J. Detection of lymph node metastasis in patients with bladder cancer using maximum standardised uptake value and 18F-fluorodeoxyglucose positron emission tomography/computed tomography: results from a high-volume centre including long-term follow-up. Eur Urol Focus. 2019;5:90–6.

Article  PubMed  Google Scholar 

Novruzov E, Dendl K, Ndlovu H, Choyke PL, Dabir M, Beu M, et al. Head-to-head intra-individual comparison of [(68)Ga]-FAPI and [(18)F]-FDG PET/CT in patients with bladder cancer. Mol Imaging Biol. 2022;24(4):651–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Filippi L, Dimitrakopoulou-Strauss A, Evangelista L, Schillaci O. Long axial field-of-view PET/CT devices: are we ready for the technological revolution? Expert Rev Med Devices. 2022;19(10):739–43.

Article  CAS  PubMed  Google Scholar 

Nadal R, Bellmunt J. Management of metastatic bladder cancer. Cancer Treat Rev. 2019;76:10–21.

Article  CAS  PubMed  Google Scholar 

Shariat SF, Palapattu GS, Karakiewicz PI, Rogers CG, Vazina A, Bastian PJ, et al. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol. 2007;51:137–51.

Article  PubMed  Google Scholar